October 09, 2020
Article
The schizophrenia drug currently has a PDUFA date set for November 15.
August 26, 2020
Tardive dyskinesia at treatment onset was the strongest predictor of schizophrenia relapse.
Telemedicine could be something that is still used, even after the COVID-19 pandemic is over.
August 25, 2020
An expert discusses ALKS 3831, a potential new treatment that demonstrated reduced weight gain in patients with schizophrenia compared to olanzapine.
August 23, 2020
The potential new treatment has demonstrated reduced weight gain in patients with schizophrenia compared to olanzapine.
August 19, 2020
Genetic and environmental liability were linked to poorer mental health in a cohort of more than 6000 individuals based in the Netherlands.
July 18, 2020
The number needed to treat to prevent at least 1 additional hospitalization was 7 individuals treated with aripiprazole once monthly compared with clinician’s choice.
July 07, 2020
The earliest time point where a treatment outcome could be observed was 1 week after initiation of medication compared to placebo.
June 01, 2020
More prospective studies are needed to examine how different drugs can be effective for schizophrenia patients based on the cluster of symptoms.
May 31, 2020
Antipsychotic discontinuation remains a major hurdle for effective schizophrenia treatment.
